EUVIMEDEUVIMED entdecken
Crossref

Liver-spleen axis: Deciphering a crucial crosstalk in non-alcoholic fatty liver disease progression and therapeutic implications

Giovanni Tarantino, Vincenzo Citro

World Journal of Gastroenterology · 14.09.2026 · 32 (34)

DOI: 10.3748/wjg.119467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 14.09.2026. Verfasst von Giovanni Tarantino und 1 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 216 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic fatty liver disease, is a highly prevalent metabolic liver disorder, closely linked to obesity, insulin resistance, and chronic low-grade inflammation. While traditionally viewed through the liver-adipose-gut axes, emerging evidence identifies the liver-spleen axis as a critical pathway in disease progression. This review examines the anatomical and portal vascular connections that facilitate direct communication between these organs, focusing on how splenic immune reprogramming—specifically involving myeloid-derived suppressor cells, natural killer/natural killer T cells, and pro-inflammatory signaling—drives the transition from simple steatosis to advanced cirrhosis. We further explore the diagnostic utility of splenic volume, metabolic activity, and stiffness as non-invasive markers that correlate with the severity of hepatic fibrosis and portal hypertension. In conclusion, the spleen serves as a vital immunometabolic regulatory hub and a sentinel for hepatic stress. Recognizing this axis offers significant potential for precision diagnostics and novel therapeutic interventions. Future research should focus on longitudinal intervention trials and multi-omics studies to fully decode the signaling crosstalk within the NAFLD spectrum, shifting the management of the disease toward a more systemic, integrated approach.

Zitieren

APA

Tarantino, G., & Citro, V. (2026). Liver-spleen axis: Deciphering a crucial crosstalk in non-alcoholic fatty liver disease progression and therapeutic implications. World Journal of Gastroenterology, 32(34). https://doi.org/10.3748/wjg.119467

Vancouver

Tarantino G, Citro V. Liver-spleen axis: Deciphering a crucial crosstalk in non-alcoholic fatty liver disease progression and therapeutic implications. World Journal of Gastroenterology. 2026;32(34). doi:10.3748/wjg.119467

BibTeX
@article{Tarantino2026,
  author = {Tarantino, Giovanni and Citro, Vincenzo},
  title = {Liver-spleen axis: Deciphering a crucial crosstalk in non-alcoholic fatty liver disease progression and therapeutic implications},
  journal = {World Journal of Gastroenterology},
  year = {2026},
  volume = {32},
  number = {34},
  doi = {10.3748/wjg.119467}
}
Kostenlos starten →